Cabometyx
Active substance: cabozantinib
cabozantinib (s)-malate
Centralised EU authorisationActive
Marketing holder: Ipsen Pharma
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Composition
- cabozantinib (s)-malate
Analogues by country
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-1693-78ef-b925-aacf70e23b50,01a12093-66e2-7eb3-b657-c1f770a1f7a2;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/004163
- Registration status
- Active
- ATC code
- L01EX07
Sources
- product · EMA · EMEA/H/C/004163 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/004163 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/004163 · Verified 2026-10-09